Skip to main content
$2.27 -$0.26 (-10.3%)

04:15 PM EDT on 09/23/20

ImmunoTech Inc (NYSEMKT:AIM)

CAPS Rating: 2 out of 5

A biopharmaceutical company engaged in the clinical development, manufacture, marketing and distribution of new drug entities based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders.

Current Price $2.27 Mkt Cap $90.1M
Open $0.00 P/E Ratio 0.00
Prev. Close $2.27 Div. (Yield) $0.00 (0.0%)
Daily Range $0.00 - $0.00 Volume 17,398
52-Wk Range $0.38 - $7.11 Avg. Daily Vol. 4,581,123

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

113 Outperform
77 Underperform
 

All-Star Players

9 Outperform
20 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NYSEMKT:AIM Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

BioPharmacist (< 20)
Submitted December 12, 2012

Gonna surprise everyone with an advisory committee panel that votes in favor of accelerated approval with phase 4 trials being required.

TrendIsMyFriend (< 20)
Submitted December 07, 2006

Ok where should I start?To my knowledge:The company burns more then 4 mil $$$ each quarter.They have just couple products.Ampligen®Alferon LDO®which have high side effects chance and at best they can sell those products for 6milThey have couple more… More

NYSEMKT:AIM VS S&P 500 (SPY)

Fools bullish on NYSEMKT:AIM are also bullish on:

Fools bearish on NYSEMKT:AIM are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about AIM.

Recs

0
Member Avatar rtovar (< 20) Submitted: 6/8/2020 5:59:32 PM : Outperform Start Price: $2.60 NYSE MKT:AIM Score: -15.47

I've followed this company carefully. Their flagship product has been proven to work on SARS, and should be effective against Corvid19. The fact that they have trials in the US and China is a plus.

Recs

0
Member Avatar SpartyFool (< 20) Submitted: 5/30/2020 1:06:20 PM : Outperform Start Price: $2.77 NYSE MKT:AIM Score: -26.10

Will take off as 5G escalates.

Recs

0
Member Avatar OklaBoston (< 20) Submitted: 3/1/2020 10:30:45 AM : Outperform Start Price: $2.30 NYSE MKT:AIM Score: -15.23

Shrinking deficit and being in a high growth industry.

Leaderboard

Find the members with the highest scoring picks in AIM.

Score Leader

TMFBiologyFool

TMFBiologyFool (75.75) Score: +365.73

The Score Leader is the player with the highest score across all their picks in AIM.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
RetestingLows 27.91 7/9/2009 Underperform 5Y $25.56 -91.31% +266.48% +357.79 0 Comment
thestockstalker < 20 5/21/2009 Underperform NS $21.60 -89.72% +264.41% +354.13 0 Comment
marginaddict < 20 6/23/2009 Underperform 3W $25.56 -91.31% +262.32% +353.63 3 Comments
soul2197 28.03 6/25/2009 Underperform 3W $22.68 -90.21% +261.54% +351.75 0 Comment
ehabob 76.48 5/28/2009 Underperform 3M $20.64 -89.24% +258.33% +347.57 0 Comment
GingerBean 35.18 6/26/2009 Underperform 5Y $28.32 -92.16% +253.27% +345.43 0 Comment
Hero4All 28.11 5/20/2009 Underperform 5Y $21.36 -89.61% +255.34% +344.95 0 Comment
raambo < 20 6/3/2009 Underperform 3W $30.24 -92.66% +250.90% +343.55 0 Comment
avatre < 20 6/8/2009 Underperform 5Y $35.88 -93.81% +247.40% +341.21 0 Comment
dannyboy124 34.30 6/15/2009 Underperform 5Y $34.20 -93.51% +246.93% +340.44 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for AIM.